Abstract:
N-alkanoyl derivatives of staurospodne represented by the formula I ##STR1## wherein R. sub. a and R. sub. b are each H or ##STR2## wherein R. sub. 1 and R. sub. 2 are independently H or --OH or --OCH. sub. 3 and R. sub. 3 is OH, NHCH. sub. 3, NCH COCH. sub. 3 or NHCOCH. sub. 3 and R. sub. 4 is OH or H and, stereochemical isomers thereof with the provisos that (1) when R. sub. a and R. sub. b. dbd. A, and R. sub. 1. dbd. H. sub. 2 or OH R. sub. 3 is not NHCH. sub. 3 ; (2) when R. sub. a and R. sub. b. dbd. B, then R. sub. 1. dbd. R. sub. 4. dbd. OH or R. sub. 1. dbd. R. sub. 4. dbd. H; (3) when R. sub. a. dbd. R. sub. b. dbd. H R. sub. 1. dbd. --OCH. sub. 3, and (4) when R. sub. a and R. sub. b. dbd. A, and R. sub. 1. dbd. H and R. sub. 2. dbd. OCH. sub. 3, then R3 is not and ##STR3## pharmaceutical compositions thereof useful for inhibiting myosin light chain kinase, protein kinase C or tumor cell proliferation as well as producing an antihypertensive effect and an anti-inflammatory effect in warm-blood animals such as man are disclosed.